Search the Newsreel

BridgeBio Pharma (BBIO) Secured Two Priority Reviews For Rare Disease Drugs

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. BridgeBio Pharma (NasdaqGS:BBIO) reports recent clinical and regulatory milestones across late-stage rare disease assets, including acoramidis, BBP-418, and encaleret. Acoramidis continues to show differentiated …

Thermo Fisher Scientific Inc. $TMO Shares Sold by Wedge Capital Management L L P NC

Wedge Capital Management L L P NC significantly reduced its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 93.3% in the second quarter, selling over 11,000 shares. Despite this, other institutional investors either increased or initiated stakes in the company, with institutional ownership remaining …

BayBridge Capital Group LLC Sells 1,729 Shares of Meta Platforms, Inc. $META

Is Ionis Pharmaceuticals (IONS) Undervalued Following Its Pullback?

Russians launch missile attack on ArcelorMittal Kryvyi Rih plant, killing two

A Russian missile strike hit the ArcelorMittal Kryvyi Rih plant on the night of August 15-16, resulting in one death and 13 injuries among employees and contractors. The attack damaged key production facilities, forcing some operations to be suspended while rescue efforts and damage …

5 Insightful Analyst Questions From Under Armour’s Q2 Earnings Call

5 Insightful Analyst Questions From Under Armour's Q2 Earnings Call Under Armour's second quarter results were met with a significant negative market reaction, as revenue fell short of Wall Street expectations and declined year over year. Management attributed the shortfall to softer consumer demand, …

Russian missile strike on "ArcelorMittal Kryvyi Rih" — two killed, 13 injured

A Russian missile strike on the "ArcelorMittal Kryvyi Rih" enterprise has resulted in two deaths and 13 injuries among employees and contractor organizations. The attack also caused significant damage to the main production facilities, leading to a partial halt in operations. Rescue efforts are …

Enemy missile attack hits ArcelorMittal Kryvyi Rih plant overnight, killing and injuring people

A Russian missile attack on the ArcelorMittal Kryvyi Rih plant overnight resulted in one fatality and several injuries, causing partial halt of production and damage to key facilities. The body of a previously missing victim was recovered from the rubble, bringing the total reported …

Russian troops strike ArcelorMittal Kryvyi Rih: two dead, main production facilities damaged

A missile strike by Russian forces on ArcelorMittal Kryvyi Rih resulted in two deaths and injuries to 13 employees and contractors. The attack damaged key production facilities in the power generation and blast furnace sectors, leading to a partial halt in the plant's production …

Russia launched a missile strike on the ArcelorMittal steel mill in Kryvyi Rih: the body of a second victim was recovered from the rubble, and there are injured people

Russian forces conducted a missile strike on the ArcelorMittal steel mill in Kryvyi Rih, resulting in at least two fatalities and fourteen injuries. The attack damaged power generation and blast furnace facilities, leading to a partial suspension of production. This is not the first …

Ionis (IONS) Stock Looks Like A Bargain On Value But Full On Sales

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Ionis Pharmaceuticals stock carries a strong three year return record alongside a high overall value score, yet current market multiples still point to the shares …

Meta (META) Stock Price Outlook 2026: $55B Ad Quarter, $145B AI Bet — Is $540 the Next Stop?

Handelsbanken Fonder AB Has $3.63 Million Holdings in Hormel Foods Corporation $HRL

Handelsbanken Fonder AB significantly increased its stake in Hormel Foods Corporation (NYSE:HRL) by 40.3% in the second quarter, bringing its total holdings to 146,200 shares valued at approximately $3.63 million. Other hedge funds also adjusted their positions in HRL, which reported quarterly earnings of …

Meta Platforms, Inc. $META Shares Sold by Fisher Funds Management LTD

Meta Platforms, Inc. $META Shares Bought by Empirical Financial Services LLC d.b.a. Empirical Wealth Management

177,782 Shares in HA Sustainable Infrastructure Capital, Inc. $HASI Acquired by Avalon Trust Co

Avalon Trust Co recently acquired 177,782 shares of HA Sustainable Infrastructure Capital, Inc. (NYSE:HASI) for approximately $6.94 million, representing about 0.14% of the company. Other institutional investors also adjusted their holdings in the real estate investment trust, which specializes in financing climate change solutions. …

Harmony Biosciences Holdings (HRMY), Why Is It Getting Fresh Attention?

Assenagon Asset Management S.A. Decreases Holdings in Alarm.com Holdings, Inc. $ALRM

Assenagon Asset Management S.A. significantly reduced its stake in Alarm.com Holdings, Inc. (ALRM) by 78% in the second quarter of 2026, selling 54,969 shares and retaining 15,473 shares valued at approximately $723,000. Despite this, Alarm.com exceeded quarterly earnings expectations with $0.77 EPS against a …

Russia attacked the largest metallurgical plant – ArcelorMittal Kryvyi Rih

Russia launched missile strikes on ArcelorMittal Kryvyi Rih, Ukraine's largest metallurgical plant, resulting in two deaths and thirteen injuries. Key production facilities were damaged, leading to a partial halt in operations. This attack is part of ongoing Russian aggression impacting Ukraine's economy, including its …

Phathom Pharmaceuticals (PHAT) Stock Sees Modest Fair Value Cut After Analyst Target Cuts

Phathom Pharmaceuticals (PHAT) has experienced a modest fair value cut from US$23.70 to US$21.50 following analyst target revisions. This adjustment is due to updated Q2 results, revised 2026 revenue guidance, and new perspectives on their drug Voquezna's commercial path. While some firms remain bullish …

ABN AMRO Bank N.V. Invests $20.21 Million in Sprouts Farmers Market, Inc. $SFM

ABN AMRO Bank N.V. has invested $20.21 million in Sprouts Farmers Market (SFM), acquiring a 0.26% stake. The investment comes amidst mixed analyst sentiment for SFM, with some near-term earnings estimates lowered due to softer comparable sales and margin pressure, despite the company slightly …

Affirm (AFRM) Shares Skyrocket, What You Need To Know

Affirm (AFRM) Shares Skyrocket, What You Need To Know What Happened? Shares of buy now, pay later company Affirm (NASDAQ:AFRM) jumped 6.9% in the afternoon session after BMO Capital Markets raised its price target on the stock, coupled with growing excitement for its upcoming …

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Consensus Rating of "Moderate Buy" by Brokerages

Tarsus Pharmaceuticals (NASDAQ:TARS) has received a "Moderate Buy" consensus rating from brokerages, with an average 12-month price target of $90.50, significantly higher than its current share price of $69.20. The company recently reported quarterly revenue of $173.91 million, surpassing estimates, but its loss per …

Citius Pharmaceuticals Reports LYMPHIR Revenue Growth, Explores CAR-T Combination

Citius Pharmaceuticals reported promising early results for its approved drug LYMPHIR in new indications, including an 86% objective response rate in a Phase 1 CAR-T combination trial for diffuse large B-cell lymphoma and a 24% ORR in gynecologic malignancies. The company also announced strong …

Will Mirum Pharmaceuticals' (MIRM) Widening Net Losses Test Its Growth-Focused Investment Narrative?

Mirum Pharmaceuticals reported a significant net loss for Q2 and H1 2026, with basic loss per share rising, which highlights increased costs relative to revenue. This widening loss intensifies focus on cash burn and funding risks, despite upcoming clinical and regulatory catalysts such as …

Wall Street Zen Downgrades Mirum Pharmaceuticals (NASDAQ:MIRM) to Sell

Wall Street Zen has downgraded Mirum Pharmaceuticals (NASDAQ:MIRM) from "hold" to "sell," despite the company reporting better-than-expected quarterly revenue of $176.24 million, a 37.9% increase year-over-year. The downgrade comes as the company missed earnings per share estimates, reporting a loss of $1.06 against a …

Responsive Playbooks and the ETON Inflection

This article provides an AI-driven analysis for Eton Pharmaceuticals Inc. (NASDAQ: ETON), highlighting weak near and mid-term sentiment but a positive long-term outlook. It details specific trading strategies including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis. The report suggests …

Harmony Biosciences (NASDAQ:HRMY) Rating Increased to Strong-Buy at Wall Street Zen

Wall Street Zen has upgraded Harmony Biosciences (NASDAQ:HRMY) from a "buy" to a "strong-buy" rating. This upgrade comes as the company reported strong quarterly earnings, beating analyst estimates with an EPS of $1.28 and a 30.3% year-over-year revenue increase to $261.28 million. Despite this, …

Rigel Pharmaceuticals (RIGL) Stock Sees Fair Value Lift As Veppanu Launch Adds Growth Hope

Rigel Pharmaceuticals (RIGL) has seen its fair value estimate increase from US$51.6 to US$61.2 per share, primarily due to the launch of Veppanu in the U.S. and the international potential of Rezlidhia through a partnership with Kissei. Analysts, such as H.C. Wainwright, view Veppanu …

Why Eton Pharmaceuticals (ETON) Is Up 32.0% After Q2 Earnings Surge And Raised 2026 Outlook

Eton Pharmaceuticals (ETON) saw its stock rise 32.0% after reporting a significant Q2 2026 earnings turnaround, with revenue surging to US$37.59 million and net income reaching US$11.58 million. The company also raised its full-year 2026 revenue guidance to at least US$145 million and expanded …

(CRMD) as a Liquidity Pulse for Institutional Tactics

Cormedix Inc. (NASDAQ: CRMD) shows a mid-channel oscillation pattern with mixed sentiment across different time horizons. An exceptional short setup is identified with a significant risk-reward ratio. The article details three AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis …

Enterprise value to revenue forward of Rhythm Pharmaceuticals, Inc. – DUS:1RV

This article provides financial data for Rhythm Pharmaceuticals, Inc. (DUS:1RV) on the Dusseldorf Stock Exchange, specifically focusing on its enterprise value to revenue forward. It notes that the market is closed with no trades recorded at the time of publication. The content is presented …

Marksans Pharma Limited (NSE:MARKSANS) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Is Under Armour (UAA) Undervalued Following Its Guidance Cut?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Under Armour (UAA) is back in focus after updating investors on both near term and full year expectations. The company paired a new …

Permian Basin Royalty Trust (NYSE:PBT) Short Interest Up 106.3% in July

Permian Basin Royalty Trust (NYSE:PBT) experienced a significant increase in short interest, rising 106.3% in July to 288,002 shares. Despite this, institutional investors have been increasing their positions, and the company recently raised its monthly dividend. PBT currently holds a consensus "Hold" rating from …

Permian Resources (PR) On Q2 Earnings And Higher Guidance Looks Cheap But Is It Priced In

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Why Permian Resources stock is back in focus after Q2 earnings Permian Resources (PR) …